Reports for CANDESARTAN CILEXETIL
Ingredient
CANDESARTAN CILEXETIL
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ATACAND | 8MG | TABLET | Resolved | 2019-01-11 | 2019-03-14 | 71981 |
| ATACAND | 8MG | TABLET | Resolved | 2020-01-17 | 2020-01-25 | 103575 |
| ATACAND | 8MG | TABLET | Resolved | 2020-02-10 | 2020-03-07 | 105629 |
| ATACAND | 8MG | TABLET | Resolved | 2020-04-29 | 2020-05-14 | 113490 |
| ATACAND | 16MG | TABLET | Resolved | 2019-01-28 | 2019-04-11 | 73737 |
| ATACAND | 16MG | TABLET | Resolved | 2020-01-17 | 2020-01-25 | 103581 |
| ATACAND | 16MG | TABLET | Resolved | 2020-02-19 | 2020-03-07 | 106664 |
| ATACAND | 32MG | TABLET | Resolved | 2019-02-06 | 2019-03-14 | 74863 |
| ATACAND | 32MG | TABLET | Resolved | 2020-02-10 | 2020-03-26 | 105632 |
| ATACAND | 32MG | TABLET | Resolved | 2020-06-10 | 2020-06-26 | 117398 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| CANDESARTAN | 4MG | TABLET | Discontinued | 2017-06-06 | 2017-06-07 | 12033 |
| MYLAN-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53611 |
| MYLAN-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-07-03 | 2018-08-11 | 53616 |
| MYLAN-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53621 |
| MYLAN-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53628 |